Pharming Group to report first quarter 2026 financial results and provide business update on May 7

Rhea-AI Summary

Pharming Group (Euronext: PHARM / Nasdaq: PHAR) will report preliminary unaudited Q1 2026 financial results and provide a business update on Thursday, May 7, 2026. Management will host a conference call and live webcast at 13:30 CEST / 07:30 EDT.

According to Pharming, investors and analysts must register in advance for dial-in or webcast access; questions will be taken only from dial-in attendees. The webcast and a replay will be available on the company investor website.

AI-generated analysis. Not financial advice.

Key Figures

Quarter: first quarter 2026 Earnings date: May 7, 2026 Conference time CEST: 13:30 CEST +2 more

5 metrics

Quarter first quarter 2026 Preliminary unaudited financial results to be reported

Earnings date May 7, 2026 Date of first quarter 2026 financial results release

Conference time CEST 13:30 CEST Scheduled start time for analyst and investor call

Conference time EDT 07:30 am EDT Scheduled start time for analyst and investor call

Publication date April 23, 2026 Date the earnings date announcement was released

Market Reality Check

normal vol

Market Pulse Summary

This announcement set the timetable for Pharming’s preliminary, unaudited first quarter 2026 financi...

Analysis

This announcement set the timetable for Pharming’s preliminary, unaudited first quarter 2026 financial results and business update on May 7, 2026, including a conference call and webcast for analysts and investors. The key takeaway is purely scheduling: no financial figures or guidance changes were disclosed. Investors may focus on the forthcoming results, management’s commentary, and any updates to strategy or outlook that emerge during the call and webcast.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Leiden, the Netherlands, April 23, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the first quarter 2026 and provide a business update on Thursday, May 7, 2026.

Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CEST/07:30 am EDT.

To participate in the conference call or to watch the live webcast, please register in advance using the links below.

Conference call registration:
https://register-conf.media-server.com/register/BI1dba0cdf00fd47289729b51369140831

Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.

Please note, the Company will only take questions from dial-in attendees.

Webcast registration:
https://edge.media-server.com/mmc/p/topu6hc2/

The webcast will also be accessible on the Pharming website at Investors/Financial Documents, and a replay will be available shortly after the event.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We develop and commercialize innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with U.S. and European operations.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Investor Relations
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

Media Relations
Global: Saskia Mehring, Head of Corporate Communications
T: +31 6 28 32 60 41
E: media.relations@pharming.com

U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

Attachment

• Pharming Group to report 1Q26 results_EN_23APR26

FAQ

When will Pharming (PHARM) report Q1 2026 results and hold its investor call?

Pharming will report preliminary Q1 2026 results and host its investor call on May 7, 2026. According to Pharming, the call and webcast start at 13:30 CEST / 07:30 EDT, with a replay posted on the company's investor website after the event.

How can investors register for the Pharming (PHARM) May 7, 2026 conference call and webcast?

Investors must register in advance for the conference call or webcast via the links provided by the company. According to Pharming, dial-in details and a unique PIN will be supplied after registration to access the live call.

Will Pharming (PHARM) take live questions during the May 7, 2026 event?

Yes, Pharming will take questions only from dial-in attendees during the live call. According to Pharming, participants who join via dial-in and use the provided PIN will be eligible to ask questions during the analyst and investor session.

Where will the Pharming (PHARM) webcast and replay be available after the May 7, 2026 presentation?

The live webcast and subsequent replay will be available on the company's investor website under Financial Documents. According to Pharming, the replay is posted shortly after the event for investors who cannot join live.

Are the Q1 2026 financial results from Pharming (PHARM) described as audited or unaudited?

Pharming describes the Q1 2026 results as preliminary and unaudited. According to Pharming, the announcement refers to preliminary unaudited financial results to be reported at the May 7, 2026 update and call.